Cyndeo Wealth Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $355K | Sell |
676
-1
| -0.1% | -$525 | 0.02% | 355 |
|
|
2025
Q1 | $429K | Sell |
677
-71
| -9% | -$45K | 0.03% | 319 |
|
|
2024
Q4 | $533K | Sell |
748
-1
| -0.1% | -$712 | 0.04% | 288 |
|
|
2024
Q3 | $787K | Sell |
749
-199
| -21% | -$209K | 0.06% | 244 |
|
|
2024
Q2 | $996K | Buy |
948
+109
| +13% | +$115K | 0.08% | 212 |
|
|
2024
Q1 | $808K | Hold |
839
| – | – | 0.07% | 221 |
|
|
2023
Q4 | $737K | Buy |
839
+3
| +0.4% | +$2.64K | 0.07% | 215 |
|
|
2023
Q3 | $688K | Buy |
836
+90
| +12% | +$74.1K | 0.07% | 199 |
|
|
2023
Q2 | $536K | Sell |
746
-2
| -0.3% | -$1.44K | 0.06% | 214 |
|
|
2023
Q1 | $615K | Sell |
748
-5
| -0.7% | -$4.11K | 0.07% | 199 |
|
|
2022
Q4 | $543K | Buy |
+753
| New | +$543K | 0.06% | 208 |
|